Stryker 2Q12: Slightly Disappointing; Searching for New CEO (Orthopedics This Week)
Stryker Corporation reported $2.106 billion in sales for the second quarter on July 18, a 5% increase on a constant currency basis. The Street had expected sales of $2.130 billion.
The company's reconstructive division, including hips, knees and trauma, increased revenue by 3.5% to $927 million. Spine sales, part of the company's neurological/spine division, rose 8.6% to $181 million.
On a constant currency basis, Stryker hip sales only rose 0.8%, knees rose 2.1% and trauma and extremities rose 9.3%. Spine sale...
